Kenvue stock is down 28% in 2025 amid controversy surrounding its Tylenol brand, which is linked to autism when used during ...

“For over a decade — and as recently as August — FDA has fully evaluated the emerging scientific evidence and repeatedly ...

Kenvue urged U.S. regulators to deny a request warning against Tylenol’s use during pregnancy, laying out the most detailed ...

Kenvue Inc. (NYSE: KVUE), spun out from Johnson & Johnson in 2023, is at a crossroads. As the world's largest pure-play ...

Kenvue has urged U.S. regulators to reject a request seeking autism warning label on its popular over-the-counter pain ...

Shares of Kenvue fell 13% Thursday to $14.11, its lowest finish since the consumer healthcare firm spun off from Johnson & ...

A potential legal headache for consumer healthcare giant Kenvue ( KVUE 8.36%) was causing pain for investors on Thursday.

Kenvue (KVUE) could really use some good news. The Johnson & Johnson (JNJ) spinoff faced longlasting troubles regarding its ...

Kenvue, the maker of Tylenol, is urging U.S. health regulators not to add an autism warning label to it and other ...

After popular pain med Tylenol came under fire from officials in the Trump administration for an alleged link to autism if ...

Kenvue, maker of Tylenol, rejects proposed label changes citing “no proven link” between acetaminophen use in pregnancy and ...

Kenvue, the maker of Tylenol, opposes proposed changes to the product's safety label regarding potential links to autism and ...